CGON
CG Oncology, Inc.
CG Oncology, Inc. (CGON) has 7 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 17, 2026.
The most active filer is Director POST LEONARD E with 4 filings. Insiders have net bought $22.1M over the trailing 6 months. The largest single insider purchase in this window was $24.8M by Director Liu Brian Guan-Chyun on Jun 25, 2026.
- Industry:Biotechnology
- CEO:Arthur Kuan
- Employees:142
- HQ:Irvine, CA, US
- IPO:2024-01-25
Insider Buying
$24.8M
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$6.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 1,000 | $71K | Jul 17 | SEC ↗ | |
| Director | Sale | 24,165 | $1.8M | Jul 14 | SEC ↗ | |
Liu Brian Guan-ChyunFirst filing | Director | Purchase | 371,085 | $24.8M | Jun 29 | SEC ↗ |
| Director | Sale | 5,000 | $350K | Jun 25 | SEC ↗ | |
| Director | Sale | 5,000 | $325K | Jun 23 | SEC ↗ | |
Mulay JamesFirst filing | Director | Sale | 1,964 | $118K | Jun 16 | SEC ↗ |
POST LEONARD EFirst filing | Director | Sale | 1,000 | $55K | Jun 5 | SEC ↗ |
Related companies
CG Oncology, Inc. is in the Healthcare sector.